Form 4 for ONC BeOne Medicines Ltd.

Accepted 2026-06-15 17:55:36 ET · period of report 2026-06-11 · accession 0001675628-26-000002 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
	2026-06-15 17:55	2026-06-11	ONC	Ball Titus B.	Principal Accounting Off	A - Grant	$0.00	+31.2K	99.6K	+46%	$0
M	2026-06-15 17:55	2026-06-11	ONC	Ball Titus B.	Principal Accounting Off	S - Sale	$257.20	-169	0	-100%	-$43.5K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Ordinary Shares	2026-06-11	A	A	31,213	$0.00	99,645	D	—	—	(F1) Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 11, 2026, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
2	Common	American Depositary Shares	2026-06-11	S	D	49	$256.39	120	D	—	—	(F2) Each American Depositary Share represents 13 Ordinary Shares. (F3) The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 10, 2025, subject to continued service.
3	Common	American Depositary Shares	2026-06-11	S	D	120	$257.53	0	D	—	—	(F2) Each American Depositary Share represents 13 Ordinary Shares. (F3) The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 10, 2025, subject to continued service.